X0304 4 2011-12-05 1 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001033409 ESHELMAN FREDRIC N 929 NORTH FRONT STREET WILMINGTON NC 28401 1 1 0 0 Executive Chairman Common Stock 2011-04-14 5 J 0 15000 0 D 394500 I GRAT Common Stock 2011-04-14 5 J 0 15000 0 A 6984741 D Common Stock 2011-12-05 4 D 0 6984741 33.25 D 0 D Common Stock 2011-12-05 4 D 0 394500 33.25 D 0 I GRAT Common Stock 2011-12-05 4 D 0 11258 33.25 D 0 I LLC Common Stock 2011-12-05 4 D 0 1685 33.25 D 0 I Spouse Stock Options (to buy) 27.27 2011-12-05 4 D 0 90000 0 D Common Stock 90000 0 D Stock Options (to buy) 20.45 2011-12-05 4 D 0 103506 0 D Common Stock 103506 0 D Stock Options (to buy) 25.74 2011-12-05 4 D 0 103506 0 D Common Stock 103506 0 D Stock Options (to buy) 19.94 2011-12-05 4 D 0 51753 0 D Common Stock 51753 0 D Stock Options (to buy) 43.26 2011-12-05 4 D 0 103506 0 D Common Stock 103506 0 D Stock Options (to buy) 32.47 2011-12-05 4 D 0 51753 0 D Common Stock 51753 0 D Stock Options (to buy) 33.44 2011-12-05 4 D 0 207012 0 D Common Stock 207012 0 D Stock Options (to buy) 20.47 2011-12-05 4 D 0 258764 0 D Common Stock 258764 0 D Stock Options (to buy) 14.78 2011-12-05 4 D 0 124207 0 D Common Stock 124207 0 D Stock Options (to buy) 14.44 2011-12-05 4 D 0 41403 0 D Common Stock 41403 0 D Restricted Stock Units 2011-12-05 4 D 0 30000 0 D Common Stock 30000 0 D Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Pharmaceutical Prodcut Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc. dated as of October 2, 2011, on the effective date of the merger contemplated by the Agreement (the "Merger"), each of these shares of common stock was automatically converted into the right to receive $33.25. The stock options were cancelled pursuant to the Agreement on the effective date of the Merger in exchange for a cash payment equal to the difference (if any ) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but vesting was accelerated due to the Merger. These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13 but vesting was accelerated due to the Merger. These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12 but vesting was accelerated due to the Merger. These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. Each restricted stock unit (RSU) represents a contingent right to receive one share of PPDI common stock. The RSUs were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but became fully vested pursuant to the terms of the Agreement. The RSUs were disposed of pursuant to the terms of the Agreement in exchange for a cash payment of $33.25 per share upon the effective date of the Merger. Lisa C. Noecker attorney-in-fact for Fred N. Eshelman 2011-12-06